The efficacy of antiarrhythmic drugs in the prevention of recurrence of aconitine-induced atrial fibrillation after electrical conversion.
D031841:Aconitum / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D001794:Blood Pressure / Q000187:drug effects; D004285:Dogs; D004554:Electric Countershock; D004562:Electrocardiography; D004983:Ethanolamines / Q000627:therapeutic use; D005260:Female; D008297:Male; D008954:Models, Biological; D010672:Phenytoin / Q000627:therapeutic use; D011433:Propranolol / Q000627:therapeutic use; D011802:Quinidine / Q000627:therapeutic use; D013997:Time Factors
D000889:Anti-Arrhythmia Agents; D004983:Ethanolamines; D010672:Phenytoin; D011433:Propranolol; D011802:Quinidine